Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.

International journal of molecular sciences - 1 Sept 2015

Owaga Eddy, Hsieh Rong-Hong, Mugendi Beatrice, Masuku Sakhile, Shih Chun-Kuang, Chang Jung-Su

Abstract excerpt

Inflammatory bowel diseases (IBD) are characterized by wasting and chronic intestinal inflammation triggered by various cytokine-mediated pathways. In recent years, it was shown that T helper 17 (Th17) cells are involved in the pathogenesis of IBD, which makes them an attractive therapeutic target. Th17 cells preferentially produce interleukin (IL)-17A-F as signature cytokines. The role of the interplay between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Intestinal Mucosa
Share to Intestines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homeostasis

Share to Immunomodulation

Share to Immunotherapy

Share to Inflammatory Bowel Diseases

Share to Probiotics

Share to Th17 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 26340622
DOI: 10.3390/ijms160920841
PMCID: PMC4613231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.PMID 26340622Read ↗

The Th17 Cell Population and the Immune Homeostasis of the Gastrointestinal TractSemantic proximity Read ↗

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.Semantic proximity Read ↗

Th17 cells in immunity and autoimmunity.Semantic proximity Read ↗

Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.Semantic proximity Read ↗

The Effect of Probiotics and Gut Microbiota on Th17 CellsSemantic proximity Read ↗

Innate and adaptive immunity in inflammatory bowel disease.Semantic proximity Read ↗

Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel diseaseSemantic proximity Read ↗

New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches.Semantic proximity Read ↗

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.Semantic proximity Read ↗

Th17 response and autophagy--main pathways implicated in the development of inflammatory bowel disease by genome-wide association studies.Semantic proximity Read ↗

Th17 plasticity and its changes associated with inflammatory bowel disease.Semantic proximity Read ↗

Th17 plasticity and its relevance to inflammatory bowel diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.